{"id":"https://openalex.org/W1701006594","doi":null,"title":"Tardive dyskinesia in affective disorders.","display_name":"Tardive dyskinesia in affective disorders.","publication_year":1999,"publication_date":"1999-01-01","ids":{"openalex":"https://openalex.org/W1701006594","mag":"1701006594","pmid":"https://pubmed.ncbi.nlm.nih.gov/10192407"},"language":"en","primary_location":{"id":"pmid:10192407","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10192407","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical psychiatry","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"J M Kane","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1302444339","display_name":"Northwell Health","ror":"https://ror.org/02bxt4m23","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1302444339"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"J M Kane","raw_affiliation_strings":["Department of Psychiatry, Hillside Hospital, Division of North Shore-Long Island Jewish Health System, Glen Oaks, NY 11004, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Hillside Hospital, Division of North Shore-Long Island Jewish Health System, Glen Oaks, NY 11004, USA","institution_ids":["https://openalex.org/I1302444339"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1302444339"],"apc_list":null,"apc_paid":null,"fwci":6.7167,"has_fulltext":false,"cited_by_count":150,"citation_normalized_percentile":{"value":0.97170268,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"60 Suppl 12","issue":null,"first_page":"43","last_page":"6"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10854","display_name":"Bipolar Disorder and Treatment","score":0.004699999932199717,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tardive-dyskinesia","display_name":"tardive dyskinesia","score":0.9890000224113464},{"id":"https://openalex.org/keywords/mood-disorders","display_name":"mood disorders","score":0.9470000267028809},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.8309999704360962},{"id":"https://openalex.org/keywords/aggression","display_name":"aggression","score":0.7329999804496765},{"id":"https://openalex.org/keywords/hostility","display_name":"hostility","score":0.6470000147819519},{"id":"https://openalex.org/keywords/clozapine","display_name":"clozapine","score":0.9800000190734863},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.9829999804496765},{"id":"https://openalex.org/keywords/substance-use-comorbidity","display_name":"substance use comorbidity","score":0.9589999914169312},{"id":"https://openalex.org/keywords/schizoaffective-disorder","display_name":"schizoaffective disorder","score":0.8830000162124634},{"id":"https://openalex.org/keywords/antiaggressive-effects","display_name":"antiaggressive effects","score":0.7379999756813049}],"concepts":[{"id":"https://openalex.org/C2779158372","wikidata":"https://www.wikidata.org/wiki/Q1546328","display_name":"Tardive dyskinesia","level":3,"score":0.9842103123664856},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.7656948566436768},{"id":"https://openalex.org/C2776619155","wikidata":"https://www.wikidata.org/wiki/Q201872","display_name":"Olanzapine","level":3,"score":0.7366839051246643},{"id":"https://openalex.org/C2780405171","wikidata":"https://www.wikidata.org/wiki/Q629444","display_name":"Dyskinesia","level":4,"score":0.6499785780906677},{"id":"https://openalex.org/C2778261627","wikidata":"https://www.wikidata.org/wiki/Q2608695","display_name":"Movement disorders","level":3,"score":0.5281688570976257},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5079851746559143},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.5048075914382935},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5037843585014343},{"id":"https://openalex.org/C2780616385","wikidata":"https://www.wikidata.org/wiki/Q1385411","display_name":"Extrapyramidal symptoms","level":4,"score":0.498309850692749},{"id":"https://openalex.org/C2775870346","wikidata":"https://www.wikidata.org/wiki/Q2554162","display_name":"Typical antipsychotic","level":5,"score":0.44135016202926636},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.43897542357444763},{"id":"https://openalex.org/C2776921671","wikidata":"https://www.wikidata.org/wiki/Q758295","display_name":"Atypical antipsychotic","level":4,"score":0.41293585300445557},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.18344518542289734},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.15812066197395325},{"id":"https://openalex.org/C2779734285","wikidata":"https://www.wikidata.org/wiki/Q11085","display_name":"Parkinson's disease","level":3,"score":0.05215677618980408}],"mesh":[{"descriptor_ui":"D000069348","descriptor_name":"Quetiapine Fumarate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077152","descriptor_name":"Olanzapine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000341","descriptor_name":"Affective Disorders, Psychotic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000341","descriptor_name":"Affective Disorders, Psychotic","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001714","descriptor_name":"Bipolar Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001714","descriptor_name":"Bipolar Disorder","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D002220","descriptor_name":"Carbamazepine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003987","descriptor_name":"Dibenzothiazepines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004409","descriptor_name":"Dyskinesia, Drug-Induced","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D010890","descriptor_name":"Pirenzepine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010890","descriptor_name":"Pirenzepine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D010890","descriptor_name":"Pirenzepine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011618","descriptor_name":"Psychotic Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018570","descriptor_name":"Risk Assessment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018849","descriptor_name":"Controlled Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018967","descriptor_name":"Risperidone","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018967","descriptor_name":"Risperidone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":3,"locations":[{"id":"pmid:10192407","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10192407","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical psychiatry","raw_type":"Journal Article"},{"id":"pmid:10372611","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10372611","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical psychiatry","raw_type":"Journal Article"},{"id":"mag:1701006594","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10192407","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G6196112304","display_name":"PROSPECTIVE STUDY OF TARDIVE DYSKINESIA IN THE ELDERLY","funder_award_id":"R01MH040015","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"}],"funders":[{"id":"https://openalex.org/F4320337346","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":27,"referenced_works":["https://openalex.org/W571162626","https://openalex.org/W1847831565","https://openalex.org/W1956321811","https://openalex.org/W1964855006","https://openalex.org/W1977746607","https://openalex.org/W1985517071","https://openalex.org/W1990975960","https://openalex.org/W2008554022","https://openalex.org/W2014036031","https://openalex.org/W2022528197","https://openalex.org/W2026039828","https://openalex.org/W2049799612","https://openalex.org/W2060802427","https://openalex.org/W2064503685","https://openalex.org/W2086362482","https://openalex.org/W2090610111","https://openalex.org/W2317803637","https://openalex.org/W2395397935","https://openalex.org/W2396378722","https://openalex.org/W2400825078","https://openalex.org/W2402363043","https://openalex.org/W2410149269","https://openalex.org/W2412241232","https://openalex.org/W2412626412","https://openalex.org/W2414146091","https://openalex.org/W2417522786","https://openalex.org/W2421308807"],"related_works":["https://openalex.org/W2132801550","https://openalex.org/W2111959578","https://openalex.org/W2003744137","https://openalex.org/W4391354031","https://openalex.org/W1979819977","https://openalex.org/W4414823260","https://openalex.org/W2082213093","https://openalex.org/W2147322097","https://openalex.org/W2097768453","https://openalex.org/W2047547804"],"abstract_inverted_index":{"Aggressive":[0],"behavior":[1],"in":[2,32,50,183,202],"schizophrenic":[3,112,206],"patients,":[4],"although":[5],"infrequent,":[6],"is":[7,36,52],"a":[8,14,37,54,96],"serious":[9],"problem.":[10,56],"It":[11],"is,":[12],"however,":[13],"relatively":[15,155],"common":[16],"reason":[17],"for":[18,31,67,89],"psychiatric":[19],"admission":[20],"and":[21,43,46,85,92,121,132,157,179,194,221,235],"poses":[22],"an":[23,134],"increasing":[24],"threat":[25],"as":[26],"more":[27,171],"patients":[28,113,127,185,207],"are":[29,79],"cared":[30],"the":[33,61,68,115,174,188,203],"community.":[34],"There":[35],"strong":[38],"association":[39],"between":[40],"substance":[41,48,210,219],"abuse":[42,49],"violent":[44],"behavior,":[45],"comorbid":[47,209],"schizophrenia":[51,224],"also":[53,181,198],"major":[55],"The":[57,149],"recent":[58],"introduction":[59],"of":[60,71,74,98,110,117,126,136,139,152,192,200,205,215,233],"atypical":[62],"antipsychotics":[63],"has":[64,104],"brought":[65],"hope":[66],"pharmacologic":[69],"management":[70],"this":[72,143],"group":[73],"patients.":[75],"These":[76,168],"newer":[77],"agents":[78],"thought":[80],"to":[81,147],"have":[82,100],"antiaggressive":[83,105,150],"effects":[84,116,151,169,175],"perhaps":[86],"decrease":[87],"cravings":[88],"illicit":[90],"substances":[91],"alcohol.":[93],"Data":[94],"from":[95],"number":[97],"studies":[99],"demonstrated":[101],"that":[102],"clozapine":[103,118,153],"effects.":[106,167],"A":[107],"retrospective":[108],"analysis":[109],"331":[111],"assessed":[114],"on":[119,176,231],"hostility":[120,193],"aggression.":[122,195],"At":[123],"baseline,":[124],"31.4%":[125],"showed":[128,187,228],"overt":[129],"physical":[130],"aggression,":[131],"after":[133],"average":[135],"47":[137],"weeks":[138],"treatment":[140,204,216],"with":[141,208,217,223],"clozapine,":[142,218],"rate":[144],"had":[145],"fallen":[146],"1.1%.":[148],"were":[154,170,180],"specific":[156],"could":[158],"not":[159],"be":[160,199],"explained":[161],"by":[162],"sedation":[163],"or":[164,225],"general":[165],"antipsychotic":[166],"pronounced":[172],"than":[173],"other":[177],"symptoms":[178],"present":[182],"those":[184],"who":[186],"highest":[189],"pretreatment":[190],"levels":[191],"Clozapine":[196],"may":[197],"benefit":[201],"abuse.":[211],"After":[212],"6":[213],"months":[214],"abusers":[220],"nonabusers":[222],"schizoaffective":[226],"disorder":[227],"similar":[229],"improvements":[230],"measures":[232],"psychopathology":[234],"psychosocial":[236],"functioning.":[237]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":3},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2016-06-24T00:00:00"}